Metastatic cutaneous apocrine adenocarcinoma successfully treated with systemic anti‐androgen therapy—A case report

Fanny Collette, Marc Hamoir, Pascal Van Eeckhout, P. Dabadie, Thierry Duprez, Sandra Schmitz, Jean‐Pascal Machiels

Clinical Case Reports · 2020 · 14 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

Primary cutaneous apocrine adenocarcinoma (PCAC) is an extremely rare neoplasm involving the sweat glands. Due to a lack of cases, there is no consensus for the systemic treatment of locally advanced or metastatic PCAC. Anti-androgen therapy may have activity in inoperable or metastatic PCAC with high androgen receptor (AR) expression.

References

19